An Open Clinical study on Oma legium (Internal) and Musuttai Ennai (External) in childrens having itching during night time

An open clinical study on sirangu(scabies) in children with the evaluation siddha trail drug Oma Legiyam(internal) with Musuttai Ennai(external)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009642

Enrollment

Registered

2017-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Sirangu (Scabies)

Interventions

Intervention1: Oma Legium (Internal) and Musuttai Ennai (External): Dosage of Oma Legium is 5 grams and of Musuttai ennai is quantity sufficient. Duration for administration of trial drugs is 21 days

Eligibility

Inclusion criteria

Inclusion criteria: 1. Nocturnal itching (particularly at night) 2. Burrows 3. Papules and Papulovesicles 4. Pustules Lesions seen in webs of hands, wrists, ulnar aspect of fore arm, elbows, axillae, feet, buttocks, palms and sole and Genital area.

Exclusion criteria

Exclusion criteria: 1. Acute glomerular nephritis 2. Eczema 3. Photo Dermatitis

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by comparing the reduction in clinical symptoms and recurrence before and after treatmentTimepoint: 21 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr M Sumathi

Govt Siddha Medical College

cspriya2004@gmail.com9444312671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026